INS and Hyperglycemia: reported that intravascular gene delivery via rAAV6-FST 317 to prediabetic db/db mice ameliorates progression of hyperglycemia, maintains insulinemia, promote abundance of insulin producing beta cell population, and reduced number of α‐like cells (159).